|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction显示文摘 | Anderson JC Carlquist JF Muhleste in JB | 1998 | J Am Collcardiol1998，32，： | 1 |
| 2 | Cardiovascular pharmacoge-nomics: current status, future prospects 显示文摘 | Anderson JL Carlquist JF Home BD | 2003 | J Cardiovasc Pharmacol Ther2003，8，1： | 1 |
| 3 | Genotypes of the cytochrome P450 isoform, CYP2C9, and thevitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study显示文摘 | CARLQUIST JF HORNE BD MUHLESTEIN JB | 2006 | Thromb Thrombolysis2006，22，3： | 1 |
| 4 | Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease 显示文摘 | Madsen TE Muhlestein JB Carlquist JF | 2005 | Am J Nephrol2005，25，1： | 1 |
| 5 | Evaluation of C-reactive protein,an inflammatory maker,and infectious serology as risk factor for coronary artery disease and myocdardial infarction显示文摘 | Anderson JL Carlquist JF Joseph B | 1998 | JACC1998，32，： | 1 |
| 6 | Evaluation of C reactive protein,an inflammation marker,and infectious serology as risk factors for coronary artery disease and myocardial infarction显示文摘 | Anderson JL Carlquist JF Muhlestein JB | 1998 | J Am Coll Cardiol1998，32，1： | 1 |
| 7 | Cytomegalovirus seropositivity and C-reactive protein have independent and combined predicative value for mortality in patients with angiographically demonstrated coronary artery disease显示文摘 | Muhlestein JB Horne BD Carlquist JF | 2000 | Circulation2000，102，： | 1 |
| 8 | Evaluation of C-reactive protein, an inflammatory marker, and infectious serology asrisk factors for coronary artery disease and myocardial infarction 显示文摘 | Anderson JL Carlquist JF Muhlestein JB | 1998 | JAm Coll Cardiol1998，32，1： | 1 |
| 9 | Genotypes of the eytochrome P450 isoform,CYP2C9,and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable dose:a prospective study显示文摘 | Carlquist JF Horne BD Muhlestein JB | | 0，，3： | 1 |
| 10 | Genotype-based dosing algorithms for warfarin therapy:data review and rec- ommendations显示文摘 | Johnson EG Home BD Carlquist JF | 2011 | Mol Diagn Ther2011，15，： | 1 |
| 11 | Lipoprotein-associated phospholipase A2:a new biomarker for cardiovascular risk assessment and potential therapeutic target显示文摘 | Carlquist JF Muhlestein JB Anderson JL | 2007 | Expert Rev Mol Diagn2007，7，5： | 1 |
| 12 | Toll-like receptor 4gene Asp299Gly polymorphism is associated with reductions in vascular inflammation,angiographic coronary artery disease,and clinical diabetes显示文摘 | Kolek MJ Carlquist JF Muhlestein JB | 2004 | Am Heart J2004，148，6： | 1 |
| 13 | Genotypes of the eytochrome P450 isoform,CYP2C9,and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable dose:a prospective study显示文摘 | Carlquist JF Home BD Muhlestein JB | 2006 | Thromb Thrombolysis2006，22，3： | 1 |
| 14 | Toll-like receptor 4gene Asp299Gly polymorphism is associated with reductions in vascular inflammation,angiographic coronary artery disease,and clinical diabetes显示文摘 | Kolek MJ Carlquist JF Muhlestein JB | 2004 | Am Heart J2004，148，6： | 1 |
| 15 | Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease显示文摘 | Home BD Muhlestein JB Carlquist JF | 2000 | J Am Coil Candid2000，36，： | 1 |
| 16 | Evaluation of C-reactive protein,an inflammation marker,and infectius serology as risk factors for coronary artery disease and myocardial infarction显示文摘 | Anderson JL Carlquist JF Muhlestein JB | 1998 | J Am Coll Cardiol1998，32，1： | 1 |
| 17 | Evaluation of Creactive protein, an inflammatory marker and infectious seology as risk factors for coronary artery disease and myocardial infarciton显示文摘 | Aderson JL Carlquist JF Muhlestein JB | 1998 | J Am Coll Cardiol1998，32，1： | 1 |
| 18 | Statin therapy,lipid levels,C-reactive protein and the surdval of patients with angiographically severe coronary artery disease显示文摘 | Muhlestein JB Carlquist JF | 2000 | J Am Coil Cardiol2000，36，6： | 1 |
| 19 | Mycoplasma pneumoniae high IgA titer but not IgG predicts increased hazard of death or myocardial infarction among patients with angiographically definned coronary artery disease显示文摘 | Lim TH Muhlestein JB Carlquist JF | 2002 | J Am Coil Cardiol2002，39，： | 1 |
| 20 | Statin therapy,lipid levels,C-reactive protein and survival of patients with angiographically severe coronary artery disease显示文摘 | Home BD Muhlestein JB Carlquist JF | 2000 | J Am Coll Cordial2000，36，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员